883 related articles for article (PubMed ID: 29805314)
1. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.
Chu F; Shi M; Lang Y; Shen D; Jin T; Zhu J; Cui L
Mediators Inflamm; 2018; 2018():8168717. PubMed ID: 29805314
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiome and multiple sclerosis: New insights and perspective.
Esmaeil Amini M; Shomali N; Bakhshi A; Rezaei S; Hemmatzadeh M; Hosseinzadeh R; Eslami S; Babaie F; Aslani S; Torkamandi S; Mohammadi H
Int Immunopharmacol; 2020 Nov; 88():107024. PubMed ID: 33182024
[TBL] [Abstract][Full Text] [Related]
3. Short-chain fatty acids and gut microbiota in multiple sclerosis.
Melbye P; Olsson A; Hansen TH; Søndergaard HB; Bang Oturai A
Acta Neurol Scand; 2019 Mar; 139(3):208-219. PubMed ID: 30427062
[TBL] [Abstract][Full Text] [Related]
4. Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.
Calvo-Barreiro L; Eixarch H; Montalban X; Espejo C
Autoimmun Rev; 2018 Feb; 17(2):165-174. PubMed ID: 29191793
[TBL] [Abstract][Full Text] [Related]
5. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
[TBL] [Abstract][Full Text] [Related]
6. Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity.
Montgomery TL; Künstner A; Kennedy JJ; Fang Q; Asarian L; Culp-Hill R; D'Alessandro A; Teuscher C; Busch H; Krementsov DN
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27516-27527. PubMed ID: 33077601
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin and MCC950 modified gut microbiota in experimental autoimmune encephalomyelitis mouse by brain gut axis.
Xu L; Zhang C; He D; Jiang N; Bai Y; Xin Y
Life Sci; 2020 Jul; 253():117747. PubMed ID: 32376270
[TBL] [Abstract][Full Text] [Related]
8. Role of intestinal microbiota in the development of multiple sclerosis.
Castillo-Álvarez F; Marzo-Sola ME
Neurologia; 2017 Apr; 32(3):175-184. PubMed ID: 26383059
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.
Berer K; Gerdes LA; Cekanaviciute E; Jia X; Xiao L; Xia Z; Liu C; Klotz L; Stauffer U; Baranzini SE; Kümpfel T; Hohlfeld R; Krishnamoorthy G; Wekerle H
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10719-10724. PubMed ID: 28893994
[TBL] [Abstract][Full Text] [Related]
10. The role of the gut microbiota and microbial metabolites in neuroinflammation.
Haase S; Wilck N; Haghikia A; Gold R; Mueller DN; Linker RA
Eur J Immunol; 2020 Dec; 50(12):1863-1870. PubMed ID: 33188704
[TBL] [Abstract][Full Text] [Related]
11. The second brain: The connection between gut microbiota composition and multiple sclerosis.
Farshbafnadi M; Agah E; Rezaei N
J Neuroimmunol; 2021 Nov; 360():577700. PubMed ID: 34482269
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis: Possibility of a gut environment-induced disease.
Sato W; Yamamura T
Neurochem Int; 2019 Nov; 130():104475. PubMed ID: 31152766
[TBL] [Abstract][Full Text] [Related]
13. The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.
Freedman SN; Shahi SK; Mangalam AK
Neurotherapeutics; 2018 Jan; 15(1):109-125. PubMed ID: 29204955
[TBL] [Abstract][Full Text] [Related]
14. Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood.
Yadav SK; Boppana S; Ito N; Mindur JE; Mathay MT; Patel A; Dhib-Jalbut S; Ito K
Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9318-E9327. PubMed ID: 29078267
[TBL] [Abstract][Full Text] [Related]
15. Disease of the holobiont, the example of multiple sclerosis.
Castillo-Álvarez F; Marzo-Sola ME
Med Clin (Barc); 2019 Feb; 152(4):147-153. PubMed ID: 30424933
[TBL] [Abstract][Full Text] [Related]
16. The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease.
Mowry EM; Glenn JD
Neurol Clin; 2018 Feb; 36(1):185-196. PubMed ID: 29157399
[TBL] [Abstract][Full Text] [Related]
17. [Multiple sclerosis and microbiota. From genome to metagenome?].
Hohlfeld R; Wekerle H
Nervenarzt; 2015 Aug; 86(8):925-33. PubMed ID: 26099498
[TBL] [Abstract][Full Text] [Related]
18. Dietary ellagic acid therapy for CNS autoimmunity: Targeting on Alloprevotella rava and propionate metabolism.
Han B; Shi L; Bao MY; Yu FL; Zhang Y; Lu XY; Wang Y; Li DX; Lin JC; Jia W; Li X; Zhang Y
Microbiome; 2024 Jun; 12(1):114. PubMed ID: 38915127
[TBL] [Abstract][Full Text] [Related]
19. Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis.
Maglione A; Zuccalà M; Tosi M; Clerico M; Rolla S
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440354
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota depletion from early adolescence alters adult immunological and neurobehavioral responses in a mouse model of multiple sclerosis.
Zeraati M; Enayati M; Kafami L; Shahidi SH; Salari AA
Neuropharmacology; 2019 Oct; 157():107685. PubMed ID: 31247271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
